What does CUSIP 717224109 represent in this 13F holders report?

CUSIP 717224109 is the security identifier for PHASQ - PHASEBIO PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in Q1 2023?

No institutional holders were reported for PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in Q1 2023; review adjacent reporting periods for trend context.

PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -557,722
Total reported value: $0
Number of holders: 0
Value change: -$15,552
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2022

Recent filing periods for CUSIP 717224109:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

Q1 2023 13F Holders as of 31 Mar 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of PHASQ - PHASEBIO PHARMACEUTICALS INC - COM as of Q1 2023.